　さて、再感染について現時点（二〇二〇年九月六日）で言えることをまとめていきましょう。

　今回のお題

　「一度感染すれば、もう大丈夫？」

　今回のまとめ

　新型コロナウィルスの再感染は、起こり得ることです。ですがそれが非常に稀な事なのか、頻繁に起きる事かは分かりません。また症状はアメリカの一例のようによく重症化するのか、再感染から再び人に移せるのか、まだまだ再感染の症例が少なすぎる為、結論を出すのは時期尚早であると考えます。

　今後最も気になること

　再感染の頻度とその後の感染力。そして再感染のリスクの差がある場合、免疫の違いの測定とその原因究明。

　参考文献リスト

[1] Centers for Disease Control and Prevention, “Flu Vaccine Safety Information,” 2019. [Online]. Available: https://www.cdc.gov/flu/prevent/general.htm. [Accessed: 03-Sep-2020].

[2] J. R. Su, P. L. Moro, C. S. Ng, P. W. Lewis, M. A. Said, and M. V Cano, “Anaphylaxis after vaccination reported to the vaccine adverse event reporting system, 1990-2016,” J. Allergy Clin. Immunol., vol. 143, no. 4, pp. 1465–1473, 2019.

[3] J. R. Chung et al., “Effects of Influenza Vaccination in the United States During the 2018–2019 Influenza Season,” Clin. Infect. Dis., Jan. 2020.

[4] K. O. Kwok, F. Lai, W. I. Wei, S. Y. S. Wong, and J. W. T. Tang, “Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries,” Journal of Infection, vol. 80, no. 6. Elsevier Ltd, pp. e32–e33, 2020.

[5] J. D. Norrie, “What policy makers need to know about COVID-19 protective immunity,” The Lancet, vol. 6736, no. 20. pp. 1527–1529, 2020.

[6] T. Britton, F. Ball, and P. Trapman, “The disease-induced herd immunity level for Covid-19 is substantially lower than the classical herd immunity level,” arXiv Prepr., pp. 1–15, 2020.

[7] U. S. Government Accountability Office, “HERD IMMUNITY FOR COVID-19,” 2020.

[8] L. Lan et al., “Positive RT-PCR Test Results in Patients Recovered From COVID-19,” JAMA, vol. 323, no. 15. pp. 1502–1503, 2020.

[9] J. An et al., “Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test,” medRxiv, 2020.

[10] L. Bao et al., “Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2,” bioRxiv, 2020.

[11] S. Roy, “COVID-19 Reinfection: Myth or Truth?,” SN Compr. Clin. Med., vol. 2, no. 6, pp. 710–713, 2020.

[12] M. L. Danzetta et al., “SARS-CoV-2 RNA Persistence in Naso-Pharyngeal Swabs,” Microorganisms, vol. 8, no. 8, pp. 1–10, 2020.

[13] Q.-X. Long et al., “Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections,” Nat. Med., vol. 26, no. 8, pp. 1200–1204, 2020.

[14] X. Wang et al., “Fecal viral shedding in COVID-19 patients: clinical significance, viral load dynamics and survival analysis,” Virus Res., p. 198147, 2020.

[15] P. Jabbari and N. Rezaei, “With Risk of Reinfection, Is COVID-19 Here to Stay?,” Disaster Med. Public Health Prep., 2020.

[16] M. Gousseff et al., “Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?,” Journal of Infection. 2020.

[17] N. M. Duggan, S. M. Ludy, B. C. Shannon, A. T. Reisner, and S. R. Wilcox, “Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results through a case report,” Am. J. Emerg. Med., 2020.

[18] S. Tomassini, D. Kotecha, P. W. Bird, A. Folwell, S. Biju, and J. W. Tang, “Setting the criteria for SARS-CoV-2 reinfection - six possible cases,” Journal of Infection. 2020.

[19] P. Kellam and W. Barclay, “The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection,” J. Gen. Virol., vol. 101, pp. 791–797, 2020.

[20] A. W. Edridge et al., “Coronavirus protective immunity is short-lasting,” medRxiv, 2020.

[21] K. K.-W. To et al., “COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing [Preprint],” Clin. Infect. Dis., vol. ciaa1275, pp. 1–25, 2020.

[22] Freunde von GISAID e.V., “GISAID,” 2020. [Online]. Available: https://www.gisaid.org/. [Accessed: 03-Sep-2020].

[23] R. L. Tillett et al., “Genomic evidence for a Case of reinfection with SARS-CoV-2 [Preprint],” Lancet, 2020.

[24] S. Halasz, “Merkel believes 60-70% of Germany’s population will be infected,” Cable News Network, 11-Mar-2020.

[25] “Can you catch the coronavirus twice? Here’s what research says.,” Advisory Board, 24-Jul-2020. [Online]. Available: https://www.advisory.com/daily-briefing/2020/07/24/covid-reinfection. [Accessed: 06-Sep-2020].

[26] L. J. A. Raddad et al., “Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting,” medRxiV, 2020.

[27] D. F. Gudbjartsson et al., “Humoral Immune Response to SARS-CoV-2 in Iceland,” N. Engl. J. Med., pp. 1–11, 2020.